Internal Server Error

About Sapient Capital

Sapient Capital is a venture capital firm founded in 2000. It is primarily based out of Los Angeles, United States. As of Mar 2010, Sapient Capital has invested in 4 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across Life Sciences and High Tech sectors. Most recently it participated in the $***** Series A round of Hemosphere Overall, Sapient Capital portfolio has seen 3 acquisitions, namely Hansen Medical, Hemosphere and Arbor Surgical Technologies. A lot of funds co-invest with Sapient Capital, with names like Kaiser Permanente Ventures sharing a substantial percentage of its portfolio. Sapient Capital has team of 46 people including 9 partners.
Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Series C
Portfolio Acquisitions

Sapient Capital's List of All Investments

Sapient Capital has a portfolio of 4 companies. Their most notable investments include Hansen Medical and ValenTx.Their portfolio spans across and United States. They have invested in Life Sciences, High Tech, across Series A, Series C stages. Here is the list of all investments by Sapient Capital:
Hansen Medical designs advanced medical robotics for positioning, manipulation and control of catheters and catheter-based technologies. Their Magellan Robotic System is an intelligent catheter for use in cardiac arrhythmia. Their first product was Sensei Robotic Catheter System. Also manufacture Artisian Extend Catherter. Acquired AorTxn (offers device solution for percutaneous replacement) in Nov, 2007.

Key facts about Hansen Medical

ValenTx is a development-stage medical device company focused on minimally invasive, non-surgical approaches for the treatment of morbid obesity and related disorders such as hypertension and type-2 diabetes. The technology uses a non-surgical, adjustable, removable, and replaceable endoluminal bypass sleeve device(the ValenTx Bypass Sleeve) to treat obesity. The company claims that its device mimics the therapeutic mechanisms of a Roux-en-Y gastric bypass but obtains these with an implantable device, that does not require surgery, gastric stapling or a permanent changes to the patient's anatomy. As of 2016, the product is yet to receive FDA approval.

Key facts about ValenTx

Hemodialysis access solutions improving patient outcomes and reducing catheter dependency. They specialize in innovative medical devices designed to improve hemodialysis access for patients with failing fistulas or grafts. Their flagship product offers a fully subcutaneous solution clinically proven to maintain long-term access, reduce infections, and improve dialysis adequacy. They provide comprehensive resources, including product finders, support videos, brochures, and educational materials for healthcare professionals. They are committed to advancing patient care through innovative medical technology and comprehensive support. Their solutions address critical needs in hemodialysis, offering alternatives to traditional catheters and improving the quality of life for patients.

Key facts about Hemosphere

Arbor Surgical Technologies is a cardiovascular device company focused on the minimally invasive heart valve replacement. It develops the modular Trilogy Aortic Valve System and sutureless TRE implantation technologies. Signed an exclusive licensing deal with Medtronic for manufacturing, marketing and distribution rights to Arbor's advanced trilobal pericardial valve technologies The company was later acquired by Medtronic.

Key facts about Arbor Surgical Technologies

Sapient Capital's Investments by Stage

Sapient Capital has made 2 investments in Series A stage with an average round size of $8.15M and 2 investments in Series C stage with an average round size of $25M.
Here are Sapient Capital's investments by stage:
Stage of entry
No. of Investments
Series A
2
Series C
2
Breakdown of Sapient Capital's investments by stage of entrySeries A (2)Series C (2)
Note: We have considered here, only first round of investments

Sapient Capital's Investments by Sector

Sapient Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech and Robotics - Industry Applications. Notably, it has invested in 4 Enterprise (B2B) companies, 4 Tech companies, 3 Software companies and 3 companies focusing on Tech hardware.
Here are Sapient Capital's investments by sector:
Sector
No. of Investments
Life Sciences
4
High Tech
1
Robotics - Industry Applications
1
Breakdown of Sapient Capital's investments by sectorsLife Sciences (4)High Tech (1)
Note: We have considered here, only first round of investments

Sapient Capital's Investments by Geography

Sapient Capital has made most investments in United States (4).

Sapient Capital's recent investments

Sapient Capital has not made any investment in 2026 so far.
Here are the most recent investments by Sapient Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Mar 31, 2010
United States
Series A
8104
Sep 08, 2009
United States
Series B
8074
  [+5]
Jan 30, 2008
United States
Series C
1980
May 2006
United States
Series A
8987
Nov 17, 2005
United States
Series C
1455

Acquired companies in Sapient Capital's Portfolio

3 companies from Sapient Capital's portfolio have been acquired. The most recent acquisition was Hansen Medical in Apr 2016 by Auris Health for $*****.
Here are Sapient Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Apr 20, 2016
Nov 17, 2005
Series C
6975
Feb 04, 2016
Mar 31, 2010
Series A
5731
Jan 28, 2008
Jan 30, 2008
Series C
4017

Team profile of Sapient Capital

Sapient Capital has a team of 46 members including 9 Partners located in United States. Sapient Capital's team does not sit on the board of any company as of now.
Here is a list of top team members in Sapient Capital:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Carmel
-
Partner
United States
-
Partner
Indianapolis
-
-
Partner
Indianapolis
-
Partner
-
-
Partner
Indianapolis
-
Partner
Indianapolis
-
Partner
Indianapolis
-
Partner
Indianapolis
-

Co-investors of Sapient Capital

Over the past 21 years, 21 investors have co-invested in Sapient Capital's portfolio companies. This includes only funds.

  • Top Co-investors of Sapient Capital: 19 investors entered a company along with Sapient Capital. These include investors like Kaiser Permanente Ventures (3 companies).
  • Invested after Sapient Capital: Medtronic (1 company) and SV Health Investors (1 company) are the investors which have invested in Sapient Capital's portfolio after their investments.

Recent News related to Sapient Capital

•
KKR & Co. Inc. $KKR Shares Sold by Sapient Capital LLCdailypolitical.com•Aug 03, 2026•KKR, Sapient Capital
View all news related to Sapient Capital

FAQs about Sapient Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford